Inverse Relation Between the tumor Necrosis Factor Promoter Methylation and Trascript Leveles in Leukocytes From Patients with Rheumatoid Arthritis.

被引:0
|
作者
Maxwell, James R.
Taylor, Lyndsey H.
Pachecho, Richardo A.
Lawrence, Neil
Duff, Gordon W. [2 ]
Teare, M. Dawn
Wilson, Anthony G. [1 ]
机构
[1] Univ Sheffield, Sect Musculoskeletal Sci, Sheffield, S Yorkshire, England
[2] Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England
来源
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
985
引用
收藏
页码:S427 / S427
页数:1
相关论文
共 50 条
  • [1] Tumor necrosis factor blockers in rheumatoid arthritis.
    Pisetsky, DS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (11): : 810 - 811
  • [2] Tumor necrosis factor promoter polymorphisms in patients with rheumatoid arthritis in Taiwan
    Yen, JH
    Chen, CJ
    Tsai, WC
    Lin, CH
    Ou, TT
    Wu, CC
    Liu, HW
    [J]. JOURNAL OF RHEUMATOLOGY, 2001, 28 (08) : 1788 - 1792
  • [3] Impact of Tumor Necrosis Factor Inhibition on Healthcare Costs in Patients with Rheumatoid Arthritis.
    Maksymowych, Walter P.
    Nguen Xuan Thanh
    Homik, Joanne
    Barnabe, Cheryl C. M.
    Martin, Liam
    Barr, Susan G.
    Ohinmaa, Arto
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S171 - S171
  • [4] Polymorphisms of tumor necrosis factor receptor I and II in patients with rheumatoid arthritis.
    Kaijzel, EL
    Bakker, AM
    van Krugten, MV
    Huizinga, TWJ
    Breedveld, FC
    Verweij, CL
    [J]. ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S194 - S194
  • [5] Polymorphism at position-308 of the promoter of the tumor necrosis factor α gene and infliximab therapy in rheumatoid arthritis.
    Fonseca, JE
    Carvalho, T
    Cruz, M
    Nero, P
    Sobral, M
    Mourao, AF
    Cavaleiro, J
    Carmo-Fonseca, M
    Branco, J
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S394 - S394
  • [6] Tumor necrosis factor-α-308 G/G promoter polymorphism correlates with a better response to adalimumab in patients with rheumatoid arthritis.
    Cuchacovich, M
    Soto, L
    Edwardes, M
    Gutierrez, M
    Llanos, C
    Pacheco, D
    Sabugo, F
    Alamo, M
    Fuentealba, C
    Villanueva, L
    Gatica, H
    Schiattino, I
    Salazar, L
    Catalán, D
    Valenzuela, O
    Salazar-Onfray, F
    Aguillón, JC
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S561 - S562
  • [7] Tumor necrosis factor and its receptor II in plasma from patients with temporomandibular joint involvement of rheumatoid arthritis.
    Alstergren, P.
    Konigsberg, A.
    Magnius, M.
    Kopp, S.
    [J]. JOURNAL OF DENTAL RESEARCH, 2003, 82 : B109 - B109
  • [8] Association of tumor necrosis factor α 5′-flanking region polymorphism with Japanese patients with rheumatoid arthritis.
    Ichikawa, N
    Kotake, S
    Hakoda, M
    Higami, K
    Kawasaki, H
    Tsuchiya, N
    Tokunaga, K
    Kamatani, N
    [J]. ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S71 - S71
  • [9] Weight gain associated with the administration of tumor necrosis factor alpha antagonists in patients with rheumatoid arthritis.
    Fonseca, JE
    Canhao, H
    Cruz, M
    Valério, B
    Castelao, W
    Mesquita, T
    Resende, C
    Macieira, C
    da Silva, JAP
    Branco, J
    Queiroz, MV
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S170 - S170
  • [10] Tumor necrosis factor-alpha gene promoter methylation in Japanese adults with chronic periodontitis and rheumatoid arthritis
    Kojima, A.
    Kobayashi, T.
    Ito, S.
    Murasawa, A.
    Nakazono, K.
    Yoshie, H.
    [J]. JOURNAL OF PERIODONTAL RESEARCH, 2016, 51 (03) : 350 - 358